Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for presentation at the American Association for Cancer Research ("AACR") Annual Meeting ...
A new liquid biopsy test using artificial intelligence models could help spot a rare type of bone and soft tissue cancer that ...
Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Researchers have introduced groundbreaking tools—from a microfluidic platform measuring breast cell 'mechanical age' to AI-driven mammogram risk assessments—that could transform breast cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results